Skip to main content
TipRanks
Go Ultimate75% OFF

Whitehawk Therapeutics (WHWK) Income Statement

503 Followers

Whitehawk Therapeutics Income Statement

Last quarter (Q3 2026), Whitehawk Therapeutics's total revenue was $0.00. In Q3, Whitehawk Therapeutics's net income was $-21.21M. See Whitehawk Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 7.14M$ 25.98M$ 24.35M$ 15.22M$ 1.12M
$ 6.38M$ -28.07M$ -27.38M$ -18.78M$ -18.55M
$ 120.78M$ 39.39M$ 44.55M$ 43.90M$ 92.67M
Depreciation and Amortization$ 79.00K$ 193.00K$ 169.00K$ 159.00K$ 105.00K
$ -20.52M$ -64.63M$ -65.36M$ -58.80M$ -36.96M
$ -114.40M$ -67.46M$ -71.93M$ -62.68M$ -111.22M
$ 93.80M$ 3.77M$ 6.17M$ 2.17M$ 1.13M
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Per Share Metrics
Basic EPS$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Diluted EPS$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Weighted Average Shares Outstanding61.89M27.03M26.92M22.51M8.87M
Weighted Average Shares Outstanding (Diluted)61.89M27.03M26.92M22.51M8.92M

Currency in USD

Whitehawk Therapeutics Earnings and Revenue History

-120M-60M060M-12000 %-8000 %-4000 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin